Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest UCB Inc. Stories

2012-12-11 12:27:23

ATLANTA, Dec. 11, 2012 /PRNewswire/ -- UCB, Inc. and the Arthritis Foundation are proud to announce the launch of "Everyday Victories," a program designed to celebrate the individual accomplishments of people succeeding with rheumatoid arthritis (RA). The program provides a platform for the 1.5 million Americans impacted by RA to share stories of their personal "everyday victories" over the condition.(1) For each victory submitted by a person living with RA, UCB will provide $1 to the...

2012-12-05 08:26:02

ATLANTA, Dec. 5, 2012 /PRNewswire/ -- Health expert and patient advocate Dr. Donnica Moore and global biopharmaceutical company UCB, Inc. are launching Choose Your Move: Take Control of RLS to shed light on the real impact of Restless Legs Syndrome (RLS) and empower those living with the disease to work with their doctor to find a treatment approach that's right for them. "Unfortunately, many people do not fully understand what it's like to live with the disease," says Dr. Moore. "RLS can...

2012-11-30 12:25:19

ATLANTA, Nov. 30, 2012 /PRNewswire/ -- In recognition of Crohn's and Colitis Awareness Week (December 1-7), UCB, Inc. is directing a national effort to educate the public about Crohn's disease and inspire those living with the condition to speak out about it. The campaign will hinge on real stories from real people succeeding in the face of Crohn's disease, adding clarity to a misunderstood condition while providing a platform for Crohn's patients to engage and draw support from one another....

2012-11-29 00:20:46

ATLANTA, Nov. 29, 2012 /PRNewswire/ -- UCB, a global biopharmaceutical company focusing on CNS and immunology treatment and research, is sponsoring key sets of VIMPAT(® )(lacosamide) C-V data at the 66(th) Annual Meeting of the American Epilepsy Society (AES) in San Diego, Calif., November 30 - December 4. "UCB recognizes the importance of investing in clinical research and is proud to present VIMPAT(® )data that support our goal of gaining additional insight into the treatment of...

2012-11-19 12:26:56

The Michael J. Fox Foundation teams with UCB, Inc. to share patient stories of living with Parkinson's disease NEW YORK, Nov. 19, 2012 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) has teamed up with the biopharmaceutical company UCB, Inc. to create the "Tell Us Your Story" Facebook campaign. The campaign aims to encourage members of the Parkinson's community to share their personal experience with the disease while raising dollars for...

2012-11-09 08:27:23

ATLANTA and BRUSSELS, Nov. 9, 2012 /PRNewswire/ -- UCB, a global biopharmaceutical company focusing on immunology treatment and research, is proud to announce new data on two compounds in its immunology portfolio for a broad range of rheumatic conditions at the American College of Rheumatology's (ACR) 2012 Annual Scientific Meeting in Washington, D.C., November 10-14. The data include posters and oral presentations on Cimzia® (certolizumab pegol) for the treatment of moderate to severe...

2012-10-18 11:25:43

ATLANTA, Oct. 18, 2012 /PRNewswire/ -- UCB, a global biopharmaceutical company focusing on immunology and neuroscience treatment and research, is marking the 2012 American College of Gastroenterology (ACG) Annual Scientific meeting in Las Vegas, Nevada by reinforcing its commitment to improving the lives of patients with Crohn's disease. UCB will present scientific data at this year's ACG meeting, October 19-24. "The annual ACG meeting gives UCB the opportunity to demonstrate our ongoing...

2012-08-15 06:26:05

ATLANTA, Aug. 15, 2012 /PRNewswire/ -- Since its launch in March 2012, the "My Four Words" project has reached thousands of people with empowering messages of living beyond the boundaries of epilepsy. Now, representatives from UCB and the Epilepsy Advocate(TM) program are inviting participants at the Epilepsy Foundation of Georgia's 29(th) Annual Magnolia Run and Walk for Epilepsy to contribute to the movement and raise awareness of epilepsy by sharing their four-word stories. WHAT:...

2012-05-18 06:25:12

ATLANTA, May 18, 2012 /PRNewswire/ -- UCB, Inc., a leading biopharmaceutical company dedicated to the research and development of treatments for severe central nervous system and immunological disorders, is marking Digestive Disease Week (DDW) 2012 in San Diego by reinforcing its commitment to improving the lives of patients with Crohn's disease. UCB will present scientific data at this year's DDW meeting. "DDW is an exciting opportunity for UCB to join its colleagues in the...

2012-04-20 06:23:59

ATLANTA, April 20, 2012 /PRNewswire/ -- Data examining the effect of Neupro® (rotigotine transdermal system) in both Parkinson's disease and Restless Legs Syndrome (RLS) will be presented at the 64th American Academy of Neurology (AAN) Annual Meeting in New Orleans, LA, between April 21-28, 2012. Key data presentations will focus on post hoc analyses of pivotal and other studies of rotigotine transdermal system and are designed to investigate the impact of rotigotine transdermal system...